Stryker Corporation announced on November 3, 2026, that its Board of Directors has elected James E. Davis to fill a vacancy on the board. The election is effective January 1, 2027. Concurrent with the election, the Board increased the authorized number of directors from 11 to 12 seats.
Mr. Davis currently serves as the Chairman, Chief Executive Officer, and President of Quest Diagnostics, a role he assumed in November 2022. He became Chairman of the Quest Board in April 2023. Prior to joining Quest in 2013, Mr. Davis served as the Chief Executive Officer of InSightec, Inc., a global medical device company. His background also includes two decades of senior management roles within General Electric’s healthcare and aviation businesses, including a five-year tenure leading GE’s MRI business. Before his corporate career, he led strategic and operating initiatives for clients of McKinsey & Company, Inc.
Mr. Davis holds a master’s degree in management from the MIT Sloan School of Management, a master’s degree in science from MIT, and a bachelor’s degree in aeronautical engineering from the University of Michigan. Stryker stated that Mr. Davis will be compensated consistent with the Company’s other non-employee directors, as detailed in its proxy statement for the 2026 annual meeting of stockholders filed with the SEC on March 23, 2026.
Regarding his appointment, Stryker’s Chair and CEO Kevin Lobo commented, “His deep healthcare experience, operational leadership and understanding of medical technology will be a strong addition as we continue to advance Stryker’s strategy and mission.”
